#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
I think the concept of absolute cost reduction is very different than bending the trend. And we can get into whether there are absolute cost reductions that we can think about within the current system and what they would mean and what they would require.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
I think the concept of absolute cost reduction is very different than bending the trend. And we can get into whether there are absolute cost reductions that we can think about within the current system and what they would mean and what they would require.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
But I think the other way to ask the question longer term is can healthcare inflation mimic GDP inflation as opposed to being 2% faster or could it fall below it? But just getting it to that level of being at the same level of GDP inflation would be an enormous, enormous move and curbing of the healthcare expenditures.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
But I think the other way to ask the question longer term is can healthcare inflation mimic GDP inflation as opposed to being 2% faster or could it fall below it? But just getting it to that level of being at the same level of GDP inflation would be an enormous, enormous move and curbing of the healthcare expenditures.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
So look, the first thing is the number one deterrent to absolute cut 25% out of the system is the extraordinarily negative shock on the economy of that type of job loss.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
So look, the first thing is the number one deterrent to absolute cut 25% out of the system is the extraordinarily negative shock on the economy of that type of job loss.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
You cannot do this without cutting jobs. The U.S. actually spends less on infrastructure as a proportion in health care services, buildings and whatnot than many other countries, actually.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
You cannot do this without cutting jobs. The U.S. actually spends less on infrastructure as a proportion in health care services, buildings and whatnot than many other countries, actually.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
But the people aspect of this, both the number of jobs and also the fact that our doctors, nurses, et cetera, are on a real wage basis paid higher than in other countries, the two of those together and other health care workers respectively, They contribute to the gap. The administrative side is the biggest gap.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
But the people aspect of this, both the number of jobs and also the fact that our doctors, nurses, et cetera, are on a real wage basis paid higher than in other countries, the two of those together and other health care workers respectively, They contribute to the gap. The administrative side is the biggest gap.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
No, no. The administrative payroll, meaning people.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
No, no. The administrative payroll, meaning people.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
Yeah, but it's the system of having to adjudicate claims and all that. Yeah, but it is mostly a people-based system.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
Yeah, but it's the system of having to adjudicate claims and all that. Yeah, but it is mostly a people-based system.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
Well, it's increasingly doing that. I mean, those of us who have more exposure to sophisticated, scaled businesses that work in the revenue cycle or the insurers who are increasingly doing this are using it.
#327 - Choices, costs, and challenges in US healthcare: insurance intricacies, drug pricing, economic impacts, and potential reforms | Saum Sutaria, M.D.
Well, it's increasingly doing that. I mean, those of us who have more exposure to sophisticated, scaled businesses that work in the revenue cycle or the insurers who are increasingly doing this are using it.